Pune, India, Aug. 17, 2022 (GLOBE NEWSWIRE) -- According to MarketStudyReport, global imaging agents market is expected to generate commendable returns by the year 2028. Growing geriatric population, high prevalence of infectious and chronic diseases, widespread adoption of advanced technologies, and focus towards reducing the hospitalization rates are some of the prime factors fueling the overall market size.
The report also highlights the primary growth stimulants, segments, and market assessment at a country-level for each region. Additionally, the document talks about the various market participants in its competitive analysis.
An overview of the regional landscape
North America
North America imaging agents market size is expected to cross the annual valuation of USD 4.6 billion by the end of 2028. This can be attributed to the growing prevalence of chronic conditions such as cancer and cardiovascular disorders, technological breakthroughs, widespread adoption of image-guided procedures, and escalating healthcare expenditure.
In terms of application spectrum, the oncology segment had generated revenues worth USD 894.4 million for North America market and is likely to reach a commendable valuation by the end of the forecast period. this can be credited to increasing number of patients with colorectal cancer in the region.
As per modality type, the computed tomography segment captured 26% market share in North America. CT scans have been gaining significant popularity given their exceptional benefits in radiation operations, biopsy, and surgeries.
Based on geographical analysis, Canada imaging agents industry is predicted to expand at 6.5% CAGR through 2028, primarily driven by high prevalence of cancer and easy product availability in the country’s healthcare settings.
Access sample pages of the report, “North America Imaging Agents Market Forecasts 2028” in detail along with the table of contents (ToC) @
https://www.marketstudyreport.com/request-a-sample/5405149/
Asia-Pacific
Asia-Pacific imaging agents market is expected to amass USD 2.7 billion by the end of 2028, owing to increased pervasiveness of chronic conditions, high spending on healthcare sector, and rising popularity of image-based treatments.
Citing the application scope, Asia-Pacific imaging agents industry size from neurology segment is likely to register 5.2% CAGR through 2028, owing to innovative product launches.
By modality type, magnetic resonance imaging segment is reckoned to witness a y-o-y growth rate of 13.6% CAGR during the study period, primarily due to explosive demand for MRI scans since the advent of COVID-19 pandemic.
Considering the geographical spectrum, India generated USD 310 million for the market participants in 2021. This can be credited to growing investments in the healthcare sector.
Access sample pages of the report, “Asia Pacific Imaging Agents Market Forecasts 2028” in detail along with the table of contents (ToC) @
https://www.marketstudyreport.com/request-a-sample/5405148/
Europe
Imaging agents market share in Europe is poised to surpass USD 3.3 billion by the end of the forecast period. Technological breakthroughs and improving healthcare infrastructure, high volume of cancer and cardiovascular patients, and increasing product cognizance are favoring the regional market outlook.
Based on the application landscape, the neurology segment was valued at USD 257.6 million in 2021, given the high demand for MRI scans, improving medical infrastructure, and surging popularity of CT scans.
Moving on to modality type, the computed tomography segment accounted for 25.6% market share in 2021, driven by the technology’s ability to provide high-quality 3D structural images. The outbreak of COVID-19 has also augmented the demand for CT scans in Europe.
As per the country-level analysis, Germany imaging agents market industry is anticipated to showcase a 4.4% CAGR through 2028, owing to favorable reimbursement policies, advanced healthcare infrastructure, and increasing R&D activities.
Access sample pages of the report, “Europe Imaging Agents Market Forecasts 2028” in detail along with the table of contents (ToC) @
https://www.marketstudyreport.com/request-a-sample/5405147/
Global Imaging Agents Market by Product Type (Revenue, USD Billion, 2017-2028)
- Gadolinium-based contrast media
- Iodinated contrast media
- Microbubble contrast media
- Barium-based contrast media
Global Imaging Agents Market by Application Scope (Revenue, USD Billion, 2017-2028)
- Oncology
- Neurology
- Cardiology
- Gastrointestinal
Global Imaging Agents Market by Modality (Revenue, USD Billion, 2017-2028)
- X-Ray
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Ultrasound
- Others
Global Imaging Agents Market by End-User Scope (Revenue, USD Billion, 2017-2028)
- Ambulatory Surgical Centers
- Hospitals
- Diagnostic & imaging centers
- Others
Global Imaging Agents Market by Regional Landscape (Revenue, USD Billion, 2017-2028)
North America
- Canada
- U.S.
Asia Pacific
- Japan
- China
- Australia
- Indiaia
- Australia
- South Korea
- Malaysia
- Taiwan
- Indonesia
- Thailand
Europe
- Germany
- France
- Italy
- UK
- Spain
- The Netherlands
- Denmark
- Russia
- Poland
- Sweden
Global Imaging Agents Market by Competitive Reach (Revenue, USD Billion, 2017-2028)
- Trivitron Healthcare
- Lantheus Medical Imaging Inc.
- Guerbet Group
- GE Healthcare
- Eli Lilly & Company
- Curium Pharma
- Bracco Diagnostics Inc.
- Beijing Beilu Pharmaceutical Co. Ltd.
- Bayer AG
- Aytu Biopharma
- Alliance Medical
Related Report:
Global Molecular Imaging Market 2022-2028
According to the global molecular imaging market is projected to reach USD 12,165 million, recording a CAGR of approximately 5.9 percent from 2022 to 2028. Molecular imaging is a field of medical imaging that focuses on imaging molecules of medical interest within living patients. Molecular imaging procedures are non-invasive, safe and painless, and are used to diagnose and manage the treatment of cancer, heart disease, brain disorders such as Alzheimer's and Parkinson's disease, gastrointestinal disorders, lung disorders, bone disorders, kidney and thyroid disorders, and more. The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global molecular imaging market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the molecular imaging industry.
About US:
Market Study Report is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, is the platform that can help you in achieving any of these objectives.
